Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

27 Apr, 2017, 13:28 ET FDA Approves Brineura™ (cerliponase alfa) for the Treatment of CLN2 Disease, a Form of Batten Disease and Ultra-Rare Pediatric Brain Disorder in Children

BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that the U.S. Food and Drug Administration (FDA) approved Brineura™ (cerliponase alfa)...


27 Apr, 2017, 12:39 ET American Dental Association Releases Resources on Genetics and Oral Health

The American Dental Association (ADA) announced new resources for dental professionals and the public related to genetics and oral...


27 Apr, 2017, 12:15 ET Scientists at Shriners Hospitals for Children re-wire cells to produce arthritis vaccine

Using a new gene-editing technology, researchers at Shriners Hospitals for Children®— St. Louis and Washington University School of Medicine have...


27 Apr, 2017, 11:14 ET Menninger Study Shows CAMS Helps Accelerate Benefits of Treatment When Used as an Inpatient Intervention for Suicidality

The Menninger Clinic, a renowned mental health care system, today announced the publication of a controlled comparison trial finding that...


27 Apr, 2017, 11:06 ET Novo Nordisk Receives FDA Approval of Saxenda® (liraglutide) injection 3 mg Label Update Including Long-Term Safety and Efficacy Data from 3-Year Trial

Novo Nordisk today announced that the US Food and Drug Administration (FDA) approved an updated product label for Saxenda® (liraglutide) injection...


27 Apr, 2017, 09:43 ET ChromaCode Raises $12 Million in Series B for Commercial Launch and Appoints Alex Dickinson as Executive Chair

ChromaCode, Inc., a molecular diagnostics company, today announced it has raised $12 million in Series B funding. This latest round is led by New...


27 Apr, 2017, 09:30 ET ASKA and TesoRx Announce TSX-011 (Oral Testosterone) Proceeding to Human Studies Following Successful PK Study Results

TesoRx Pharma LLC and ASKA Pharmaceutical Co., Ltd. announced that, based on the successful results of recently completed preclinical PK study,...


27 Apr, 2017, 09:08 ET Ipsen en France renforce son engagement dans le domaine de la gastro-entérologie et oriente son modèle commercial vers l'OTx[a]

- Ipsen s'engage dans un nouveau domaine, le microbiote - Lorsque le microbiote est altéré, il s'agit d'une dysbiose Les...


27 Apr, 2017, 08:30 ET DelMar to Present Poster of Clinical Research with VAL-083 in Patients with Chemo-Resistant Glioblastoma ("GBM") at ASCO Annual Meeting

DelMar Pharmaceuticals (Nasdaq: DMPI) ("DelMar" and the "Company"), a biopharmaceutical company focused on the development and commercialization of...


27 Apr, 2017, 08:06 ET Meta-Analysis of Published Trials Supports the Extrapolation of Antiepileptic Drug Efficacy Data from Adult to Pediatric Patients with Primary Generalized Tonic-Clonic Seizures

Eisai Inc. announced today the presentation of results from a new meta-analysis of published clinical trials showing that the effect of adjunctive...


27 Apr, 2017, 08:00 ET Foamix Pharmaceuticals to Present at the 42nd Annual Deutsche Bank Health Care Conference

Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), ("Foamix"), a clinical stage specialty pharmaceutical company focused on developing and commercializing...


27 Apr, 2017, 07:46 ET Volition makes progress with its Colorectal Cancer Screening Triage Test in both Asia and Europe

Volition (NYSE MKT: VNRX) has commenced its first study in Asia - an evaluation of the Nu.QTM Colorectal Cancer Triage product in a Taiwanese...


27 Apr, 2017, 07:01 ET PIQUR Receives EMA Orphan Drug Designation for PQR309 in Diffuse Large B-Cell Lymphoma

PIQUR Therapeutics AG, a Swiss clinical-stage pharmaceutical company, announced today that the European Medicines Agency (EMA) has granted orphan...


27 Apr, 2017, 06:54 ET CryoLife Announces On-X Aortic Heart Valve PROACT Study Results to be Presented at American Association for Thoracic Surgery Centennial Meeting

CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that results from...


26 Apr, 2017, 17:58 ET Midazolam Nasal Spray (USL261) Phase 3 Trial Meets Primary Efficacy Endpoint In Patients With Seizure Clusters

Proximagen Limited (Proximagen) today announced that its pivotal Phase 3 trial of intranasal midazolam (USL261) for the rescue treatment of seizure...


26 Apr, 2017, 17:00 ET NanoViricides CEO Dr. Seymour to Present an Update on the Company at The Planet Microcap Showcase - 2017 in Las Vegas; Company Says it is Close to Declaring a Clinical Candidate for the Treatment of Shingles

NanoViricides, Inc. (NYSE MKT: NNVC) (the "Company"), reports that Eugene Seymour, MD, MPH, CEO, will present information about the Company and its...


26 Apr, 2017, 16:13 ET FH Foundation's FOCUS analysis shows that regardless of medical need, prescriptions for PCSK9 inhibitors are being rejected at high rates

The Familial Hypercholesterolemia Foundation today published a study in Circulation revealing high rejection rates for PCSK9 inhibitors in the two...


26 Apr, 2017, 16:05 ET Jazz Pharmaceuticals Announces Positive Results from the Phase 3 TONES 2 Study of JZP-110 in Narcolepsy Patients with Excessive Sleepiness

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced positive efficacy results from the global multicenter study of JZP-110 in adult patients...


26 Apr, 2017, 13:55 ET Braeburn Pharmaceuticals Achieves Primary Endpoint in Pivotal Phase 2/3 Study of BB0817, Risperidone 6-month Implant for Treatment of Schizophrenia

Braeburn Pharmaceuticals announced today that a 6-month study of the safety, tolerability and pharmacokinetics of transferring patients diagnosed...


26 Apr, 2017, 09:00 ET electroCore Announces Data Presentation at the 69th American Academy of Neurology Annual Meeting

electroCore, a neuroscience and technology company dedicated to improving patient outcomes through technological advancement, announced today that...


26 Apr, 2017, 09:00 ET Research Grants Available for Rare Diseases from National Organization for Rare Disorders (NORD)

The National Organization for Rare Disorders (NORD), the leading independent nonprofit organization representing the 30 million Americans with rare...


26 Apr, 2017, 08:32 ET New Clinical Study Demonstrates Benefits of RESPeRATE for Heart Failure Patients

2breathe Technologies Ltd. with its wholly owned U.S. subsidiary Resperate Inc. announced, today, the publication of a new peer reviewed original...


26 Apr, 2017, 08:30 ET Entest BioMedical's Chairman Discusses its Subsidiary, Zander Therapeutics, Inc.'s Progress With Small Molecule Immunotherapies for Treating Cancer and Arthritis in Dogs

Entest BioMedical Inc.'s (OTCPINK: ENTB) Chairman and CEO David Koos discussed current and anticipated developments for the company's subsidiary,...


26 Apr, 2017, 08:00 ET DarioHealth Expands Global Presence With Direct-to-Consumer Launch in the U.K.

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced the launch of...


26 Apr, 2017, 07:00 ET Mercator MedSystems Announces First Enrollment in the TANGO Trial for BTK Vascular Disease

Mercator MedSystems, Inc., a medical technology company, announced today the first patient enrollment into the TANGO (Temsirolimus Adventitial...